Effects of interleukin-2 on hepatitis B vaccination in uraemic patients
- PMID: 7968055
Effects of interleukin-2 on hepatitis B vaccination in uraemic patients
Comment on
-
Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine.Lancet. 1994 Sep 24;344(8926):856-7. doi: 10.1016/s0140-6736(94)92829-0. Lancet. 1994. PMID: 7916403 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
